Equity of timely access to liver and stomach cancer surgery for Indigenous patients in New Zealand: a national cohort study.
ONCOLOGY
PUBLIC HEALTH
SURGERY
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
29 04 2022
29 04 2022
Historique:
entrez:
29
4
2022
pubmed:
30
4
2022
medline:
4
5
2022
Statut:
epublish
Résumé
When combined, liver and stomach cancers are second only to lung cancer as the most common causes of cancer death for the indigenous Māori population of New Zealand-with Māori also experiencing substantial disparities in the likelihood of survival once diagnosed with these cancers. Since a key driver of this disparity in survival could be access to surgical treatment, we have used national-level data to examine surgical procedures performed on Māori patients with liver and stomach cancers and compared the likelihood and timing of access with the majority European population. We examined all cases of liver and stomach cancers diagnosed during 2007-2019 on the New Zealand Cancer Registry (liver cancer: 866 Māori, 2460 European; stomach cancer: 953 Māori, 3192 European) and linked these cases to all inpatient hospitalisations that occurred over this time to identify curative and palliative surgical procedures. As well as descriptive analysis, we compared the likelihood of access to a given procedure between Māori and Europeans, stratified by cancer and adjusted for confounding and mediating factors. Finally, we compared the timing of access to a given procedure between ethnic groups. We found that (a) access to liver transplant for Māori is lower than for Europeans; (b) Māori with stomach cancer appear more likely to require the type of palliation consistent with gastric outlet obstruction; and (c) differential timing of first stomach cancer surgery between Māori and European patients. However, we may also be cautiously encouraged by the fact that differences in overall access to curative surgical treatment were either marginal (liver) or absent (stomach).
Identifiants
pubmed: 35487720
pii: bmjopen-2021-058749
doi: 10.1136/bmjopen-2021-058749
pmc: PMC9058766
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e058749Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
N Z Med J. 2013 Oct 18;126(1384):42-52
pubmed: 24162629
Cancer Causes Control. 2017 Dec;28(12):1417-1427
pubmed: 29027594
Am J Transplant. 2009 Dec;9(12):2662-8
pubmed: 20021478
Br J Cancer. 2015 Nov 3;113(9):1375-80
pubmed: 26461060
Aust N Z J Public Health. 2013 Dec;37(6):520-6
pubmed: 24892150
J Clin Epidemiol. 2014 May;67(5):586-95
pubmed: 24582212
Am J Public Health. 2000 Aug;90(8):1212-5
pubmed: 10936998
N Z Med J. 2020 Jan 17;133(1508):43-64
pubmed: 31945042
Liver Transpl. 2021 Feb;27(3):434-443
pubmed: 33615698
Emerg Themes Epidemiol. 2007 May 14;4:3
pubmed: 17498317
ANZ J Surg. 2017 Nov 18;88(7-8):683-689
pubmed: 29150888
Ann Oncol. 2016 Sep;27(suppl 5):v38-v49
pubmed: 27664260
N Z Med J. 2020 Aug 21;133(1520):15-26
pubmed: 32994590
Hepatology. 2021 Aug;74(2):926-936
pubmed: 34128254
Cancer. 2010 Jul 1;116(13):3205-14
pubmed: 20564634
JCO Glob Oncol. 2020 Jun;6:766-774
pubmed: 32511067
N Z Med J. 2020 Sep 4;133(1521):77-96
pubmed: 32994639
ANZ J Surg. 2013 Jan;83(1-2):36-41
pubmed: 23253098
Can J Public Health. 2012 May 09;103(8 Suppl 2):S7-11
pubmed: 23618071
J Epidemiol Community Health. 2010 Feb;64(2):117-23
pubmed: 20056966
Gastric Cancer. 2015 Jul;18(3):571-9
pubmed: 25098927